TCR2 THERAPEUTICS INC (TCRR)

US87808K1060 - Common Stock

1.48  -0.09 (-5.73%)

After market: 1.53 +0.05 (+3.38%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-3-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
131.37M122.85M96.08M68.70M51.38M
Research and Development
105.05M98.42M73.58M51.98M37.49M
Selling, General, and Administrative Expenses
26.32M24.44M22.50M16.72M13.89M
Operating Income
-131.37M-122.85M-96.08M-68.70M-51.38M
Interest Income/Expense
2.93M1.94M224.00K1.74M3.89M
Other Income/Expense
N/AN/AN/AN/AN/A
Non Recurring Items
-34.43M-30.64M-3.66MN/AN/A
Income Before Taxes
-162.87M-151.56M-99.52M-66.96M-47.50M
Income Tax
228.00K261.00K289.00K160.00K100.00K
Net Income
-163.10M-151.82M-99.81M-67.12M-97.50M
EBITDA
-128.42M-119.81M-93.25M-67.11M-50.52M
 
Per Share Data
EPS Diluted Total Ops
-4.20-3.93-2.63-2.40-4.62
Non GAAP EPS
-4.20-3.93-2.63-2.43-6.43
 
Statistics

All data in USD

Charts